Allogene Therapeutics (ALLO)
(Real Time Quote from BATS)
$2.98 USD
+0.09 (3.11%)
Updated Apr 29, 2024 01:34 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: -- |
3/2024 | $-0.39 | -3.94% |
Earnings Summary
For their last quarter, Allogene Therapeutics (ALLO) reported earnings of -$0.43 per share, beating the Zacks Consensus Estimate of $-0.47 per share. This reflects a positive earnings surprise of 8.51%. Look out for ALLO's next earnings release expected on May 01, 2024. For the next earning release, we expect the company to report earnings of -$0.39 per share, reflecting a year-over-year increase of 42.65%.
Earnings History
Price & Consensus
Zacks News for ALLO
Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
ALLO: What are Zacks experts saying now?
Zacks Private Portfolio Services